Literature DB >> 17081634

Placental Plasmodium falciparum infection: causes and consequences of in utero sensitization to parasite antigens.

Kelly Broen1, Kim Brustoski, Ilka Engelmann, Adrian J F Luty.   

Abstract

Available evidence suggests that, in African populations, systemic blood-dwelling parasitoses of mothers are associated with enhanced susceptibility to infection of their offspring. Thus, children born to mothers with filariasis or schistosomiasis are infected earlier, and offspring of mothers with placental Plasmodium falciparum at delivery, commonly referred to as pregnancy-associated malaria or PAM, are themselves at higher risk of developing parasitaemia during infancy. Since foetal/neonatal antigen-presenting cells (APC) are either immature or provide insufficient costimulatory signals to T cells, thus favouring tolerance induction, it is commonly assumed that soluble parasite components [protein antigens], transferred transplacentally and inducing foetal immune tolerance, are largely, if not exclusively, responsible for these outcomes. Plasmodial asexual blood stage antigen-specific T cells are detectable in as many as two-thirds of all cord blood samples in malaria-endemic countries of sub-Saharan Africa, indicating that in utero sensitization may be a common phenomenon during pregnancy in these populations. Parasite antigen-specific T cell responses of neonates born to helminth-infected mothers display a highly skewed Th2-type cytokine pattern, with a prominent role for the regulatory cytokine interleukin (IL)-10. Similarly, the cord blood immune response of those born to mothers identified with on-going PAM is characterised by inducible parasite antigen-specific IL-10-producing regulatory T cells that can inhibit both APC HLA expression and Th1-type T cell responses. In contrast, plasmodial antigen-specific Th1-type responses, characterised by IFN-gamma production, predominate in cord blood of those born to mothers successfully treated for Pf malaria during gestation, suggesting that the duration and/or the nature of antigen exposure in utero governs the outcome with respect to neonatal immune responses. Aspects of APC function in the context of these differentially modulated responses, whether and how the latter translate into altered susceptibility to Pf infection during infancy, as well as the possible implications for vaccination in early life, are aspects that are discussed in this review.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17081634     DOI: 10.1016/j.molbiopara.2006.10.001

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  43 in total

1.  Placental malaria-associated suppression of parasite-specific immune response in neonates has no major impact on systemic CD4 T cell homeostasis.

Authors:  Valérie Soulard; Martin Amadoudji Zin; Catherine Fitting; Samad Ibitokou; Mayke Oesterholt; Adrian J F Luty; René-Xavier Perrin; Achille Massougbodji; Philippe Deloron; Antonio Bandeira; Nadine Fievet
Journal:  Infect Immun       Date:  2011-04-25       Impact factor: 3.441

2.  Cord blood Vγ2Vδ2 T cells provide a molecular marker for the influence of pregnancy-associated malaria on neonatal immunity.

Authors:  Cristiana Cairo; Nyaradzo Longinaker; Giulia Cappelli; Rose G F Leke; Manuel Mve Ondo; Rosine Djokam; Josephine Fogako; Robert J Leke; Bertrand Sagnia; Samuel Sosso; Vittorio Colizzi; C David Pauza
Journal:  J Infect Dis       Date:  2013-12-10       Impact factor: 5.226

Review 3.  The immune response to malaria in utero.

Authors:  Margaret E Feeney
Journal:  Immunol Rev       Date:  2019-09-25       Impact factor: 12.988

Review 4.  HIV-exposed uninfected children: a growing population with a vulnerable immune system?

Authors:  L Afran; M Garcia Knight; E Nduati; B C Urban; R S Heyderman; S L Rowland-Jones
Journal:  Clin Exp Immunol       Date:  2014-04       Impact factor: 4.330

5.  Human immunodeficiency virus co-infection increases placental parasite density and transplacental malaria transmission in Western Kenya.

Authors:  Steven D Perrault; Jan Hajek; Kathleen Zhong; Simon O Owino; Moses Sichangi; Geoffrey Smith; Ya Ping Shi; Julie M Moore; Kevin C Kain
Journal:  Am J Trop Med Hyg       Date:  2009-01       Impact factor: 2.345

6.  Unraveling the impact of malaria exposure before birth.

Authors:  Lars Hviid
Journal:  PLoS Med       Date:  2009-07-28       Impact factor: 11.069

7.  Can prenatal malaria exposure produce an immune tolerant phenotype? A prospective birth cohort study in Kenya.

Authors:  Indu Malhotra; Arlene Dent; Peter Mungai; Alex Wamachi; John H Ouma; David L Narum; Eric Muchiri; Daniel J Tisch; Christopher L King
Journal:  PLoS Med       Date:  2009-07-28       Impact factor: 11.069

8.  Plasmodium falciparum exposure in utero, maternal age and parity influence the innate activation of foetal antigen presenting cells.

Authors:  Nadine Fievet; Stefania Varani; Samad Ibitokou; Valérie Briand; Stéphanie Louis; René Xavier Perrin; Achille Massougbogji; Anne Hosmalin; Marita Troye-Blomberg; Philippe Deloron
Journal:  Malar J       Date:  2009-11-05       Impact factor: 2.979

9.  Placental malaria is associated with reduced early life weight development of affected children independent of low birth weight.

Authors:  Brigitte Walther; David J C Miles; Sarah Crozier; Pauline Waight; Melba S Palmero; Olubukola Ojuola; Ebrima Touray; Marianne van der Sande; Hilton Whittle; Sarah Rowland-Jones; Katie L Flanagan
Journal:  Malar J       Date:  2010-01-14       Impact factor: 2.979

10.  Antibody-dependent transplacental transfer of malaria blood-stage antigen using a human ex vivo placental perfusion model.

Authors:  Karen May; Markus Grube; Indu Malhotra; Carole A Long; Sanjay Singh; Kishor Mandaliya; Werner Siegmund; Christoph Fusch; Henning Schneider; Christopher L King
Journal:  PLoS One       Date:  2009-11-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.